Additional file 3 of Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity

Additional file 3: Table S1. Summary of the human subject brains. Overall, 1 control human brain tissues were used; age, gender, race and other relevant information is provided in sheet 1. For AD human samples, we obtained 13 and 23 human brain tissues with amyloid scores 2 and 3, respectively. All the relevant information are provided for each human sample, including their gender, age, race, postmortem time (PMT), clinical Braak stage, CERAD scores, etc.